Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pacific Edge Ltd logo — Specialists in the discovery of diagnostic and prognostic te...

Pacific Edge Ltd

Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer.

Founded 2001 New Zealand New Zealand 100 employees

General Information

Company Name Pacific Edge Ltd
Founded Year 2001
Location New Zealand New Zealand +3
Employees 100
Social

Get notified when Pacific Edge Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pacific Edge Ltd

Pacific Edge Limited (NZX/ ASX: PEB) is a global cancer diagnostics company leading the way in the development and commercialisation of bladder cancer diagnostic and prognostic tests for patients presenting with hematuria or surveillance of recurrent disease. Headquartered in Dunedin, New Zealand, the company provides its suite of Cxbladder tests globally through its wholly owned, and CLIA certified, laboratories in New Zealand and the USA. Cxbladder is a non-invasive genomic urine test optimized for the detection and management of bladder cancer. The Cxbladder evidence portfolio developed over the past 14 years includes more than 20 peer reviewed publications for primary detection, surveillance, adjudication of atypical urine cytology and equivocal cystoscopy. Cxbladder is the focal point of numerous ongoing and planned clinical studies to generate an ever-increasing body of clinical utility evidence supporting adoption and use in the clinic to improve patient health outcomes. Cxbladder is reimbursed by CMS and has been used by over 4,400 US urologists in the diagnosis and management of more than 100,000 patients, including the option for in-home sample collection. In New Zealand, Cxbladder is accessible to 75% of the population via public healthcare and all residents have the option of buying the test online. Learn more at: www.cxbladder.com

No funding data available for Pacific Edge Ltd yet.

Get notified when Pacific Edge Ltd raises funding

Pacific Edge Ltd Alternatives & Competitors

Pacific Edge Ltd vs
Micromedic Technologies Ltd.
Micromedic Technologies Ltd. Israel

Micromedic Technologies specializes in the development and commercialization of innovative in vitro...

Post Ipo Equity
1 employees
Health Care
Pacific Edge Ltd vs
Blueberry Diagnostics
Blueberry Diagnostics Spain

The new gold standard for cancer detection and prevention

11 employees
Biotechnology, Health Care
Pacific Edge Ltd vs
Arquer Diagnostics
Arquer Diagnostics United Kingdom

Leading the way in non-invasive tests for diagnosing and monitoring cancer.

Convertible Note
3 employees
Biotechnology, Health Care

FAQ About Pacific Edge Ltd

Specialists in the discovery of diagnostic and prognostic tests for the better detection and management of cancer.
Pacific Edge Ltd was founded in 2001.
Pacific Edge Ltd is headquartered in New Zealand.
Pacific Edge Ltd has approximately 100 employees.
Top alternatives and competitors to Pacific Edge Ltd include Micromedic Technologies Ltd., Blueberry Diagnostics, Arquer Diagnostics, Wren Laboratories, Mirxes. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pacific Edge Ltd and Micromedic Technologies Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pacific Edge Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy